Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Antagoniste aldostérone")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 534

  • Page / 22
Export

Selection :

  • and

La spironolactone dans l'hirsutisme idiopathique, évaluations clinique et biologique du traitement = Spironolactone in idiopathic hirsutism. Clinical and biological evaluations of treatmentABRAMOVICI, Y; GUILLET, F; MATTE, R et al.Annales d'endocrinologie. 1983, Vol 44, Num 6, pp 393-396, issn 0003-4266Article

Stereoselective synthesis of the two major metabolites of spironolactone, 3α- and 3β-hydroxy-7α-methylthio-17α-pregn-4-ene-21,17-carbolactoneGUO LI; YAN ZHANG.Steroids. 2007, Vol 72, Num 6-7, pp 569-572, issn 0039-128X, 4 p.Article

Determination of an aldosterone antagonist in urine by high-performance liquid chromatography using automated column switchingTIMM, U; SANER, A.Journal of chromatography. 1986, Vol 378, Num 1, pp 25-34, issn 0021-9673Article

ESSAI CLINIQUE DU VEROSPIRONE ET DE LA SPIRONOLACTONEGABOR G; BEKES M; POLAK G et al.1972; THERAP. HUNGAR.; HONGR.; DA. 1972; VOL. 20; NO 1-2; PP. 49-59; BIBL. 25REF.Serial Issue

KLINISCHE ERFAHRUNGEN BEI DER ANWENDUNG VON OSYROL 100 UND OSYROL PRO INJECTIONE. = EXPERIENCES CLINIQUES DE L'UTILISATION D'OSYROL 100 ET D'OSYROL INJECTABLEGORBACH HC; BRAEUNINGER HJ.1975; MUENCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 117; NO 37; PP. 1483-1486; ABS. ANGLArticle

CHROMOLIPID (CEROID) NATURE OF ADRENAL SPIRONOLACTONE BODIES = NATURE CHROMOLIPIDIQUE DES PARTICULES SURRENALIENNES DE SPIRONOLACTONEJAFFE R.1972; ISRAEL J. MED. SCI.; ISRAEL; DA. 1972; VOL. 8; NO 7; PP. 992-993; BIBL. 6REF.Serial Issue

Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolitesGARDINER, P; SCHRODE, K; QUINLAN, D et al.Journal of clinical pharmacology. 1989, Vol 29, Num 4, pp 342-347, issn 0091-2700Article

Pharmacokinetics of spironolactone and potassium canrenoate in humansKOJIMA, K; YAMAMOTO, K; FUJIOKA, H et al.Journal of pharmacobio-dynamics. 1985, Vol 8, Num 3, pp 161-166, issn 0386-846XArticle

ALDOSTERONE ANTAGONISTS IN CLINICAL MEDICINE1978; EXCERPTA MED., INTERNATION. CONGR. SER.; NLD; DA. 1978; NO 460; PP. 1-527; BIBL. DISSEM.Conference Paper

TRAITEMENT DE L'HYPERTENSION ARTERIELLE ESSENTIELLE PAR LA SPIRONOLACTONE: SON INTERET DANS LE DEPISTAGE DES HYPERALDOSTERONISMES PRIMAIRES ET PREDICTION DE SON EFFICACITEFOURNIER A; LAGRUE G; NAKACHE JP et al.1973; SEM. HOP., THERAPEUT.; FR.; DA. 1973; VOL. 49; NO 2; PP. TH. 127-TH. 130; BIBL. 7 REF.Serial Issue

L'EFFET DE L'HYDROCHLOROTHIAZIDE ET DE L'ALDACTONE SUR LES SYSTEMES COAGULANT ET ANTICOAGULANT DU SANGGAYANOVA MN.1973; KARDIOLOGIJA; S.S.S.R.; DA. 1973; VOL. 13; NO 5; PP. 114-117; BIBL. 9REF.Serial Issue

INTERACTION OF SPIRONOLACTONE AND INDOMETHACIN AT THE RENAL LEVEL = INTERACTION DE LA SPIRONOLACTONE ET DE L'INDOMETHACINE AU NIVEAU DES REINSHOFMANN LM; GARCIA HA.1972; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1972; VOL. 141; NO 1; PP. 353-355; BIBL. 7REF.Serial Issue

Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenatesLUZZANI, F; GLASSER, A.Biochemical pharmacology. 1984, Vol 33, Num 14, pp 2277-2281, issn 0006-2952Article

Spironolactone in the treatment of premenstrual tension : a double-blind study of spironolactone versus bendroflumethiazide and placeboASLAKSEN, K; FALK, V.Current therapeutic research. 1991, Vol 49, Num 1, pp 120-130, issn 0011-393X, 11 p.Article

Protective effect of spironolactone on endothelial cell apoptosisWILLIAMS, Tracy A; VERHOVEZ, Andrea; MILAN, Alberto et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 5, pp 2496-2505, issn 0013-7227, 10 p.Article

Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humansCOOK, Chyung S; BERRY, Loren M; BIBLE, Roy H et al.Drug metabolism and disposition. 2003, Vol 31, Num 11, pp 1448-1455, issn 0090-9556, 8 p.Article

THE INFLUENCE OF ALDOSTERONE AND ANTICONVULSANT DRUGS ON ELECTROENCEPHALOGRAPHIC AND CLINICAL DISTURBANCES INDUCED BY THE SPIROLACTONE DERIVATIVE, POTASSIUM CANRENOATE = INFLUENCE DE L'ALDOSTERONE ET DES MEDICATIONS ANTICONVULSIVANTES SUR LES TROUBLES CLINIQUES ET ELECTROENCEPHALOGRAPHIQUES INDUITS PAR LE DERIVE DE LA SPIROLACTONE, LE CANRENOATE DE POTASSIUMMERTIN J; SIMON O; SCHMIEDEK P et al.1975; J. NEUROL. SCI.; NETHERL.; DA. 1975; VOL. 24; NO 1; PP. 13-20; BIBL. 21REF.Article

CEREBRAL UPTAKE OF A 3H-LABELLED SPIROLACTONE COMPOUND IN THE DOG = FIXATION CEREBRALE D'UNE SPIROLACTONE MARQUEE AU 3H CHEZ LE CHIEN1973; EUROP. J. PHARMACOL.; NETHERL.; DA. 1973; VOL. 21; NO 2; PP. 238-241; BIBL. 15 REF.Serial Issue

THE EFFECT OF AN ALDOSTERONE ANTAGONIST ON THE PROTECTIVE ACTION OF CARBENOXOLONE ON THE GASTRIC MUCOSAL BARRIER. = L'EFFET D'UN ANTAGONISTE DE L'ALDOSTERONE SUR L'ACTION PROTECTRICE DE LA CARBENOXOLONE SUR LA BARRIERE DE LA MUQUEUSE GASTRIQUEREES WDW; RHODES J; CROSS S et al.1975; J. PHARM. PHARMACOL.; G.B.; DA. 1975; VOL. 27; NO 12; PP. 903-906; BIBL. 12 REF.Article

THE EFFECT OF SALURETICS AND SPIRONOLACTONE ON ALDOSTERONE PRODUCTION AND ELECTROLYTE EXCRETION IN MAN = L'EFFET DES SALURETIQUES ET DE LA SPIRONOLACTONE SUR LA PRODUCTION D'ALDOSTERONE ET L'EXCRETION DES ELECTROLYTES CHEZ L'HOMMEERBLER HC.1974; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1974; VOL. 286; NO 2; PP. 145-156; BIBL. 11REF.Article

EXPERIENCE WITH THE USE OF AN ALDOSTERONE ANTAGONIST IN SELECTED HYPERTENSIVE PATIENTS = RESULTATS DE L'UTILISATION D'UN ANTAGONISTE DE L'ALDOSTERONE CHEZ CERTAINS MALADES HYPERTENDUSKERT MJ; TARR LW; FRANKLIN S et al.1972; ANGIOLOGY; U.S.A.; DA. 1972; VOL. 23; NO 10; PP. 617-627; BIBL. 18 REF.Serial Issue

DIE BEHANDLUNG SCHWER BEEINFLUSSBARER OEDENE BEIMNEPHROTISCHEN SYNDROM = LE TRAITEMENT DE L'OEDEME REBELLE DANS LE SYNDROME NEPHROTIQUEMOST E; TILLMANN P; LOEW H et al.1976; MED. WELT; DTSCH.; DA. 1976; VOL. 27; NO 8; PP. 379-382; BIBL. 13 REF.Article

THE EFFECT OF POTASSIUM CHLORIDE AND SPIRONOLACTONE ON THIAZIDE-INDUCED POTASSIUM DEPLETION IN PATIENTS WITH ESSENTIAL HYPERTENSION = ACTION DU CHLORURE DE POTASSIUM ET DE LA SPIRONOLACTONE SUR LA DEPLETION POTASSIQUE INDUITE PAR THIAZIDIQUE DANS L'HYPERTENSION ESSENTIELLEIBSEN H.1974; ACTA MED. SCAND.; SUEDE; DA. 1974; VOL. 196; NO 1-2; PP. 21-26; BIBL. 22REF.Article

PLACE DE LA SOLUDACTONE EN REANIMATION CHIRURGICALEROCHET D.1973; SCI. MED.; FR.; DA. 1973; VOL. 4; NO 2; PP. 169-175; BIBL. 1P.Serial Issue

LES SPIROLACTONES EN THERAPEUTIQUE CARDIOLOGIQUESALVADOR M; COUDERC JJ; MARCO J et al.1972; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1972; VOL. 8; NO 8; PP. 1295-1308 (8P.)Serial Issue

  • Page / 22